Resources from the same session
Who should get an I-O combination?
Presenter: Marina Garassino
Session: Maximising the benefit of immuno-oncology
Resources:
Slides
Webcast
Biomarkers
Presenter: Naiyer Rizvi
Session: Maximising the benefit of immuno-oncology
Resources:
Slides
Webcast
What to do post-IO failure
Presenter: Pilar Garrido Lopez
Session: Maximising the benefit of immuno-oncology
Resources:
Slides
Webcast
Emerging targets in immunotherapy
Presenter: Solange Peters
Session: Maximising the benefit of immuno-oncology
Resources:
Slides
Webcast